Events: detail
4th Event Biosimilars Conference
- Hosted by:
- visiongain
- Speaker:
-
Linda R. Horton, Partner, Hogan & Hartson, Dr Rustom Mody, Director & Head – Strategic Research, R&D and Quality, Intas Biopharmaceuticals
Elona Baum, Director, Policy and Management Operations, Regulatory/Quality/Compliance, Genentech, Lore Unt, Counsel for Intellectual Property, Federal Trade Commission (FTC)
Tom Saylor, Chief Executive Offi cer, Arecor, Diane Edquist Dorman, Vice President for Public Policy, National Organization for Rare Disorders (NORD)
Marc Martens, Senior Associate, Bird & Bird, Dr Arnon Chait, President and CEO, Analiza
James Harris, Chief Effective Offi cer, Healthcare Economics, Dr Antony C Tridico, Partner, Biotechnology/Pharmaceutical Pratice Group, Finnegan Henderson
Arnold I. Friede, Counsel, McDermott Will & Emery, Robin Howard, Director, Simon–Kucher & Partners
Cecil Nick, Vice President Biotechnology, Parexel, Dr Jacco Keja, Managing Director and Practice Leader, Quintiles Global Consulting Services
- Starts:
- November 11, 2008 at 09:00 am
- Ends:
- November 13, 2008 at 05:30 pm
- Location:
- Radisson Plaza -Warwick Hotel, philadephia, philadelphia, PA.
- Maps:
Description
With a variety of different reasons for and against the development of biosimilars within the USA, generic manufacturers, originators and payers have differing views as to how this should come about. This event will provide you with practical insights into the scientifi c developments and regulatory challenges that will influence the success of biosimilars/follow-on biologics market. Enabling you with a platform to discuss the issues effecting the market, such as product selection and payer acceptance in a broader industry context. Consideration will be given to the evaluation of unwanted immunogenicity of follow-on biologicals, from preclinical development, through clinical trials, and into the post-registration period to minimise the risks associated with immunogenicity in recipients of therapeutic products.
In the interest of creating an arena for involved companies and organizations, 4th Annual Biosimilars conference will focus on:
Identify the trends that will shape future market development of follow-on
biologics
Explore the current market and regulatory environment for biosimilars in Europe
and the relevance to US legislation
Understand interchangeability/substitutibility policies
Discuss unwanted immunogenicity issues for biosimilars
Analyse the market impact of biosimilars from the Payers perceptionExamine the pre-marketing hurdles and post-marketing challenges faced by
biosimilar/follow-on biologics developers:
Utilise new and established analytical tools for demonstrating comparability
Utilise new and established analytical tools for demonstrating comparability
Assess how is the landscape evolving for biosimilar medicines
- Registration required:
- Yes
- Free:
- No
Additional information
Prices
Attendance of 2 day conference and workshop is £899.00 + VAT per person (Normal price: £1,299.00 + VAT per person) .
Attendance of 2 day conference only is £799.00 + VAT per person (Normal price: £1,299.00 + VAT per person)
Attendance of workshop only is £499.00 + VAT per person (Normal price: £599.00 + VAT per person)
Promotional Literature DistributionPromotional literature to all conference attendees (Exclude: Delegate Places) is £999.00 + VAT You can promote your organization to all the attendees at this event and you can do this by distributing your company’s promotional literature which will be inserted in the conference delegate pack. It will give you further expose to some of the world’s leaders within pharmaceutical
CD-Rom
I would not be able to attend but would like to purchase the conference. (Presentations – audio)
The CD-Rom will be shipped within 5-10 days after the conference – CD Rom is £400.00 + VAT – (Normal price: £550.00 + VAT)
There could be further discount for multiple bookings.
Registration Procedure
Method 1 – Please complete the booking form on the last page of the programme/PDF with preferred method of payment for each person and scan & email to juan.nwankpa@visiongainglobal.com
Method 2 – Complete the booking form on the last page of the programme/PDF with preferred method of payment for each person and fax to Visiongain on +0044 020 7 549 9932.
In both above instance please write “JUAN NWANKPA” on the booking form in order to deal with the registration for this conference. (All bookings will be confirmed).
Method 3 – Forward an email to juan.nwankpa@visiongainglobal.com with names of people and job title, telephone number, email, company address, and your requirements with preferred method of payment. (Credit card please state details).
Please do not hesitate to contact me for further assistance.
For more information
- Contact person:
- Juan Nwankpa
- Phone:
- +4420 754999 53
- Email:
- juan.nwankpa [ at ] visiongainglobal.com
- Website:
- 4th Event Biosimilars Conference